BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12928421)

  • 1. Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells.
    Hladik F; Desbien A; Lang J; Wang L; Ding Y; Holte S; Wilson A; Xu Y; Moerbe M; Schmechel S; McElrath MJ
    J Immunol; 2003 Sep; 171(5):2671-83. PubMed ID: 12928421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons.
    Schmechel SC; Russell N; Hladik F; Lang J; Wilson A; Ha R; Desbien A; McElrath MJ
    Immunol Lett; 2001 Nov; 79(1-2):21-7. PubMed ID: 11595286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of HIV-1 specific T lymphocyte responses in highly exposed persistently seronegative Chinese.
    Liu HW; Hong KX; Ma J; Yuan L; Liu S; Chen JP; Zhang YZ; Ruan YH; Xu JQ; Shao YM
    Chin Med J (Engl); 2006 Oct; 119(19):1616-21. PubMed ID: 17042974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than the frequencies of IFN-gamma-secreting cells: anti-HIV cytotoxicity is not generally impaired relative to other chronic virus responses.
    Snyder-Cappione JE; Divekar AA; Maupin GM; Jin X; Demeter LM; Mosmann TR
    J Immunol; 2006 Feb; 176(4):2662-8. PubMed ID: 16456029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.
    Gea-Banacloche JC; Migueles SA; Martino L; Shupert WL; McNeil AC; Sabbaghian MS; Ehler L; Prussin C; Stevens R; Lambert L; Altman J; Hallahan CW; de Quiros JC; Connors M
    J Immunol; 2000 Jul; 165(2):1082-92. PubMed ID: 10878387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.
    Kaul R; Plummer FA; Kimani J; Dong T; Kiama P; Rostron T; Njagi E; MacDonald KS; Bwayo JJ; McMichael AJ; Rowland-Jones SL
    J Immunol; 2000 Feb; 164(3):1602-11. PubMed ID: 10640781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high frequency of HIV type 1-specific cellular immune responses in seronegative individuals with parenteral and/or heterosexual HIV type 1 exposure.
    Murashev BV; Nazarenko OV; Akulova EB; Artemyeva AK; Verevochkin SV; Shaboltas AV; Skochilov RV; Toussova OV; Kozlov AP
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1598-605. PubMed ID: 22475222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    Cao J; McNevin J; Holte S; Fink L; Corey L; McElrath MJ
    J Virol; 2003 Jun; 77(12):6867-78. PubMed ID: 12768006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.
    Kaul R; Rowland-Jones SL; Kimani J; Fowke K; Dong T; Kiama P; Rutherford J; Njagi E; Mwangi F; Rostron T; Onyango J; Oyugi J; MacDonald KS; Bwayo JJ; Plummer FA
    Immunol Lett; 2001 Nov; 79(1-2):3-13. PubMed ID: 11595284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya.
    Alimonti JB; Kimani J; Matu L; Wachihi C; Kaul R; Plummer FA; Fowke KR
    Immunol Cell Biol; 2006 Oct; 84(5):482-5. PubMed ID: 16942489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.
    Norris PJ; Moffett HF; Brander C; Allen TM; O'Sullivan KM; Cosimi LA; Kaufmann DE; Walker BD; Rosenberg ES
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):315-25. PubMed ID: 15117455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
    Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
    Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans.
    Kebba A; Kaleebu P; Serwanga J; Rowland S; Yirrell D; Downing R; Gilmour J; Imami N; Gotch F; Whitworth J
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):67-75. PubMed ID: 15000700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.
    Musey L; Ding Y; Elizaga M; Ha R; Celum C; McElrath MJ
    J Immunol; 2003 Jul; 171(2):1094-101. PubMed ID: 12847284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.
    Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT
    Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.